Greenberg Roger A RA

Show results for

Transcriptomics (2)
Proteomics (1)

Organisms

Homo sapiens (2)
Varroa destructor (1)
Neisseria gonorrhoeae MS11 (1)
Juglans regia (1)
Clostridium butyricum (1)
Blautia producta (1)
Aspergillus terreus (1)
Candidatus Thiodiazotropha sp. (1)
Methanocaldococcus jannaschii (1)
Canis lupus lupus (1)
Sarbecovirus (1)
human gammaherpesvirus 4 (1)
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2-4 (1)
Lucinoma kazani (1)
Salmonella enterica subsp. enterica serovar Typhimurium str. 98346 (1)
Acinetobacter sp. (1)
NEWT:94323 (1)
Octopus vulgaris (1)
Bartonella henselae (1)
Verticillium dahliae JR2 (1)
Anopheles stephensi (1)
Pandanus amaryllifolius (1)
Azospirillum brasilense FP2 (1)
Solanum melongena (1)
Mycobacterium tuberculosis H37RvAE (1)
Zymoseptoria tritici IPO323 (1)
Agrobacterium tumefaciens (1)
Amblyomma cajennense (1)
Ralstonia pseudosolanacearum (1)
Homo sp. (1)

Repository

biostudies-arrayexpress (2)
pride (1)

Tissue

Early embryonic cell (1)
Cell culture (1)

Disease

Disease free (1)

Technology Type

Bottom-up proteomics (1)
Mass Spectrometry (1)

Publication Date

2008 (2)
2026 (1)

Study type

Comparative genomic hybridization by array (1)
Transcription profiling by array (1)

Release Date

2008 (2)

Lab affiliation

Department of Cancer Biology, University of Pennsylvania (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

iPOND mass sepctrometry (iPOND-MS) in BRCA1-A complex deficient cells treated with CPT in combination with an ATM inhibitor

iPOND Mass spectrometry (iPOND-MS) was performed to identify replication fork proteome in wild type (WT) and ABARAXAS KO (ABX KO) HEK293T cells treated with 1 µM CPT in combination with 250 nM ATM inhibitor (AZD0156). An additional set of control cells were kept for no-click (NC) negative control. T...

ORGANISM(S): Homo sapiens (Human)

2026-06-15 | PXD077767 | Pride

Gene expression analysis in primary human renal tumors, categorized by VHL genotype and HIF-alpha expression

Human renal cell carcinomas (RCC) have differential expression of HIF-1alpha and HIF-2alpha, depending on VHL genotype and other events. Here, we have divided a series of RCC samples for HIF-alpha expression and VHL genotype, in order to define differentially expressed genes Keywords: Patient Sampl...

ORGANISM(S): Homo sapiens

2008-12-27 | E-GEOD-11904 | biostudies-arrayexpress

Array CGH analysis in primary human renal tumors, categorized by VHL genotype and HIF-alpha expression

Human renal cell carcinomas (RCC) have differential expression of HIF-1alpha and HIF-2alpha, depending on VHL genotype and other events. Here, we have divided a series of RCC samples based on HIF-alpha expression, in order to examine levels of genomic DNA aberration. Keywords: Patient Sample Study ...